These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8536369)

  • 1. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis.
    Schriefer A; Barral A; Carvalho EM; Barral-Netto M
    Clin Exp Immunol; 1995 Dec; 102(3):535-40. PubMed ID: 8536369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
    De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
    Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
    Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
    Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
    Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
    Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
    Uchio E; Matsumoto T; Tanaka SI; Ohno S
    Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased immune activation during and after physical exercise.
    Tilz GP; Domej W; Diez-Ruiz A; Weiss G; Brezinschek R; Brezinschek HP; Hüttl E; Pristautz H; Wachter H; Fuchs D
    Immunobiology; 1993 Jun; 188(1-2):194-202. PubMed ID: 8104879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity.
    Douds AC; Lim AG; Jazrawi RP; Finlayson C; Maxwell JD
    J Hepatol; 1997 Feb; 26(2):280-6. PubMed ID: 9059947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis: comparison of immunological markers in patients with acute and remission phase.
    De Pità O; Ruffelli M; Cadoni S; Frezzolini A; Biava GF; Simom R; Bottari V; De Sanctis G
    J Dermatol Sci; 1996 Nov; 13(2):118-24. PubMed ID: 8953411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.
    Höbarth K; Hallas A; Steiner G; Gomahr A; Aulitzky W; Marberger M
    Urol Res; 1996; 24(2):101-6. PubMed ID: 8740979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
    Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
    Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of serum sICAM-1 and sCD4 & sCD8 in patients with nasopharyngeal carcinoma].
    Wang L; Shu M; Wei Q; Xiang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):596-8. PubMed ID: 15515547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulated cellular immune system in patients with congestive heart failure.
    Fuchs D; Samsonov M; Tilz GP; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):111-4. PubMed ID: 8490055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
    Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
    J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures.
    Beckham JC; Caldwell DS; Peterson BL; Pippen AM; Currie MS; Keefe FJ; Weinberg JB
    J Clin Immunol; 1992 Sep; 12(5):353-61. PubMed ID: 1430106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.